
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $826.9M | $1.1B | $1B | $1.1B | $1.1B | |
Revenue Growth (YoY) | 12.16% | 34.12% | -7.89% | 6.2% | 0.79% | |
Cost of Revenues | $723.8M | $990.9M | $923.5M | $975.1M | $989.9M | |
Gross Profit | $103.1M | $118.2M | $98.1M | $109.8M | $103.6M | |
Gross Profit Margin | 12.47% | 10.66% | 9.6% | 10.12% | 9.47% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $7.8M | $9.2M | $10.9M | $12.1M | $11.8M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $69M | $85.1M | $80M | $92.6M | $94.7M | |
Operating Income | $34.1M | $33.1M | $18M | $17.2M | $8.9M | |
Net Interest Expenses | $1.3M | $1.1M | $1.5M | $2.1M | $3M | |
EBT. Incl. Unusual Items | $32.5M | $31.2M | $16.1M | $15M | $5.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5.9M | $8M | $4.6M | $4.7M | $757.7K | |
Net Income to Company | $26.6M | $23.2M | $11.4M | $10.4M | $5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $26.6M | $23.2M | $11.4M | $10.4M | $5M | |
Basic EPS (Cont. Ops) | $0.66 | $0.58 | $0.28 | $0.26 | $0.13 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.58 | $0.28 | $0.26 | $0.13 | |
Weighted Average Basic Share | $39.9M | $39.9M | $40M | $40M | $39.9M | |
Weighted Average Diluted Share | $40M | $40M | $40M | $40M | $39.9M | |
EBITDA | $44.7M | $46.4M | $30.7M | $31.1M | $24.2M | |
EBIT | $33.7M | $32.3M | $17.5M | $17.1M | $8.6M | |
Revenue (Reported) | $826.9M | $1.1B | $1B | $1.1B | $1.1B | |
Operating Income (Reported) | $34.1M | $33.1M | $18M | $17.2M | $8.9M | |
Operating Income (Adjusted) | $33.7M | $32.3M | $17.5M | $17.1M | $8.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $252.9M | $266.3M | $239.6M | $261.4M | $244.7M | |
Revenue Growth (YoY) | 36.92% | 5.28% | -10.01% | 9.11% | -6.39% | |
Cost of Revenues | $225.5M | $239.2M | $217.6M | $235.4M | $226.1M | |
Gross Profit | $27.5M | $27M | $22M | $26.1M | $18.6M | |
Gross Profit Margin | 10.86% | 10.16% | 9.19% | 9.97% | 7.61% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $20.6M | $20.6M | $21.4M | $23.6M | $21.4M | |
Operating Income | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M | |
Net Interest Expenses | $1.3M | $112.2K | $322.2K | -- | $1.5M | |
EBT. Incl. Unusual Items | $5.5M | $6.2M | $322.2K | $2.5M | -$4.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.4M | $1.5M | $322.2K | $1.2M | -- | |
Net Income to Company | $4.1M | $4.7M | -- | $1.3M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $4.1M | $4.7M | -- | $1.3M | -$4.2M | |
Basic EPS (Cont. Ops) | $0.11 | $0.12 | -- | $0.03 | -$0.11 | |
Diluted EPS (Cont. Ops) | $0.11 | $0.11 | -- | $0.03 | -$0.11 | |
Weighted Average Basic Share | $39.9M | $40M | $40M | $40M | $39.9M | |
Weighted Average Diluted Share | $40M | $40M | $40M | $40M | $39.9M | |
EBITDA | $10.5M | $9.8M | $4.1M | $6.3M | $1.3M | |
EBIT | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M | |
Revenue (Reported) | $252.9M | $266.3M | $239.6M | $261.4M | $244.7M | |
Operating Income (Reported) | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M | |
Operating Income (Adjusted) | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $898.2M | $1.1B | $994.1M | $1.1B | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $787.2M | $1B | $900.8M | $993.4M | $981.3M | |
Gross Profit | $111.1M | $117.5M | $93.2M | $113.8M | $95.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $74.4M | $85.2M | $80.9M | $94.7M | $92.7M | |
Operating Income | $36.7M | $32.3M | $12.3M | $19.1M | $3.2M | |
Net Interest Expenses | $2.1M | -- | $1.6M | $1.8M | $4.4M | |
EBT. Incl. Unusual Items | $34.3M | $31.6M | $10.3M | $17.2M | -$993.8K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.3M | $8.2M | $3.4M | $5.5M | -$262.7K | |
Net Income to Company | $27.9M | $23.8M | $6.7M | $11.7M | -$533.6K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $28M | $23.5M | $6.8M | $11.6M | -$518.2K | |
Basic EPS (Cont. Ops) | $0.71 | $0.59 | $0.17 | $0.29 | -$0.01 | |
Diluted EPS (Cont. Ops) | $0.71 | $0.58 | $0.17 | $0.29 | -$0.01 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $48.2M | $45.5M | $25M | $33.3M | $19.2M | |
EBIT | $36.2M | $31.5M | $11.8M | $19.1M | $3.2M | |
Revenue (Reported) | $898.2M | $1.1B | $994.1M | $1.1B | $1.1B | |
Operating Income (Reported) | $36.7M | $32.3M | $12.3M | $19.1M | $3.2M | |
Operating Income (Adjusted) | $36.2M | $31.5M | $11.8M | $19.1M | $3.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $252.9M | $266.3M | $239.6M | $261.4M | $244.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $225.5M | $239.2M | $217.6M | $235.4M | $226.1M | |
Gross Profit | $27.5M | $27M | $22M | $26.1M | $18.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $20.6M | $20.6M | $21.4M | $23.6M | $21.4M | |
Operating Income | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M | |
Net Interest Expenses | $1.3M | $112.2K | $322.2K | -- | $1.5M | |
EBT. Incl. Unusual Items | $5.5M | $6.2M | $322.2K | $2.5M | -$4.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.4M | $1.5M | $322.2K | $1.2M | -- | |
Net Income to Company | $4.1M | $4.7M | -- | $1.3M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $4.1M | $4.7M | -- | $1.3M | -$4.2M | |
Basic EPS (Cont. Ops) | $0.11 | $0.12 | -- | $0.03 | -$0.11 | |
Diluted EPS (Cont. Ops) | $0.11 | $0.11 | -- | $0.03 | -$0.11 | |
Weighted Average Basic Share | $39.9M | $40M | $40M | $40M | $39.9M | |
Weighted Average Diluted Share | $40M | $40M | $40M | $40M | $39.9M | |
EBITDA | $10.5M | $9.8M | $4.1M | $6.3M | $1.3M | |
EBIT | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M | |
Revenue (Reported) | $252.9M | $266.3M | $239.6M | $261.4M | $244.7M | |
Operating Income (Reported) | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M | |
Operating Income (Adjusted) | $6.9M | $6.4M | $644.4K | $2.5M | -$2.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $13.8M | $1M | $4.5M | $9.8M | $3.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $12.8M | $10.6M | $11.9M | $16.2M | $12.4M | |
Inventory | $115.1M | $150.4M | $122.4M | $129.6M | $136.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $113.2K | $107.2K | $221.1K | -$104.1K | |
Total Current Assets | $149.3M | $172M | $147M | $163M | $165.6M | |
Property Plant And Equipment | $60.6M | $57.4M | $49.3M | $53.1M | $52.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $17.2M | $15.9M | $15M | $15.5M | $14.8M | |
Other Intangibles | $6.1M | $7.2M | $6.2M | $5.1M | $3.9M | |
Other Long-Term Assets | $123K | -$113.2K | $107.2K | -- | -$104.1K | |
Total Assets | $235.3M | $254.2M | $219.4M | $238.4M | $237.6M | |
Accounts Payable | $12.5M | $7.7M | $7.5M | $10.4M | $10M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $10.6M | $10.8M | $10M | $11.4M | $11.3M | |
Other Current Liabilities | $123K | -$113.2K | $107.2K | $110.5K | -- | |
Total Current Liabilities | $50.7M | $78M | $52.8M | $64.6M | $77.6M | |
Long-Term Debt | $18.3M | $14.7M | $16.6M | $14.6M | $12.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $117.7M | $134.5M | $103.3M | $114.9M | $124.1M | |
Common Stock | $123K | $113.2K | $107.2K | $110.5K | $104.1K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $117.6M | $119.7M | $116.1M | $123.6M | $113.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $117.6M | $119.7M | $116.1M | $123.6M | $113.4M | |
Total Liabilities and Equity | $235.3M | $254.2M | $219.4M | $238.4M | $237.6M | |
Cash and Short Terms | $13.8M | $1M | $4.5M | $9.8M | $3.1M | |
Total Debt | $20.8M | $28.9M | $24.5M | $22.7M | $35.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $468.9K | $2M | $1.7M | $1.1M | $32.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $24.1M | $19M | $21.3M | $24.8M | $22.3M | |
Inventory | $143.5M | $163.2M | $134.2M | $147.1M | $121.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -$117.2K | -$111.6K | $109K | -- | -- | |
Total Current Assets | $168.2M | $184.6M | $160.6M | $173.5M | $181.9M | |
Property Plant And Equipment | $63.7M | $57.1M | $48.5M | $51.8M | $54M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $16.4M | $15.6M | $15.3M | $15.1M | $15.5M | |
Other Intangibles | $6.6M | $7M | $6.1M | $4.5M | $3.1M | |
Other Long-Term Assets | -$117.2K | -$111.6K | -- | -- | -$108.2K | |
Total Assets | $256.6M | $266.1M | $232.2M | $246.8M | $255.4M | |
Accounts Payable | $47.1M | $42.2M | $33.8M | $43M | $45.1M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $10.7M | $10.7M | $10.1M | $11M | $11.4M | |
Other Current Liabilities | -- | -- | $109K | -$108K | $108.2K | |
Total Current Liabilities | $72.6M | $84.3M | $65.8M | $86.3M | $83.2M | |
Long-Term Debt | $16.4M | $18.5M | $15.6M | $4.3M | $23.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $140.6M | $143.3M | $114M | $124.8M | $141.2M | |
Common Stock | $117.2K | $111.6K | $109K | $108K | $108.2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $116.1M | $122.8M | $118.2M | $121.9M | $114.2M | |
Total Liabilities and Equity | $256.6M | $266.1M | $232.2M | $246.8M | $255.4M | |
Cash and Short Terms | $468.9K | $2M | $1.7M | $1.1M | $32.3M | |
Total Debt | $27.2M | $46.3M | $33.8M | $32.9M | $47.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $26.6M | $23.2M | $11.4M | $10.4M | $5M | |
Depreciation & Amoritzation | $11M | $14.1M | $13.2M | $14M | $15.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $2.4M | -$2M | $843.7K | -$4.1M | $865.9K | |
Change in Inventories | -$25.9M | -$46.9M | $16.2M | -$3M | -$16M | |
Cash From Operations | $11.6M | $8.6M | $27.5M | $27.3M | $2.7M | |
Capital Expenditures | $5.6M | $8.8M | $3.3M | $1.9M | $4.1M | |
Cash Acquisitions | -- | -- | -- | -- | -$324.7K | |
Cash From Investing | -$5.6M | -$8.8M | -$3.3M | -$1.9M | -$4.4M | |
Dividends Paid (Ex Special Dividend) | -$10.5M | -$11.4M | -$8.4M | -$6.5M | -$7.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $11.4M | $42M | $25.7M | $28M | $56.7M | |
Long-Term Debt Repaid | -$14.3M | -$31.9M | -$28.5M | -$30.5M | -$42.6M | |
Repurchase of Common Stock | -$571K | -- | -- | -- | -$865.9K | |
Other Financing Activities | -- | $236.6K | -- | -- | $649.4K | |
Cash From Financing | -$23M | -$11.7M | -$21.3M | -$19.9M | -$5.4M | |
Beginning Cash (CF) | $31.5M | $13.3M | $949.1K | $4.5M | $9.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$16.9M | -$11.8M | $3M | $5.4M | -$7.1M | |
Ending Cash (CF) | $12.8M | $1.1M | $4.4M | $9.6M | $3.2M | |
Levered Free Cash Flow | $6.1M | -$118.3K | $24.3M | $25.3M | -$1.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.1M | $4.7M | -- | $1.3M | -$4.2M | |
Depreciation & Amoritzation | $3.6M | $3.4M | $3.4M | $3.8M | $4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$4.9M | $1.2M | -$2.7M | -$2.6M | $105.2K | |
Change in Inventories | -$35.2M | -$15.4M | -$10.2M | -$21.8M | $20.5M | |
Cash From Operations | -$15.9M | -$12.7M | -$8.7M | -$17.6M | $23.1M | |
Capital Expenditures | $1.4M | $1.5M | $429.6K | $1.3M | $1.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.4M | -$1.6M | -$429.6K | -$1.3M | -$1.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $8.7M | $24.8M | $15.5M | $14.9M | $10.5M | |
Long-Term Debt Repaid | -$1.2M | -$6.7M | -$6.7M | -$4M | -$210.5K | |
Repurchase of Common Stock | -- | -- | -- | -$217.2K | -- | |
Other Financing Activities | -$120.5K | -$112.2K | $107.4K | $869K | -$631.3K | |
Cash From Financing | $4.8M | $15.3M | $6.2M | $8.7M | $6.7M | |
Beginning Cash (CF) | $13.5M | $1M | $4.5M | $9.7M | $3.2M | |
Foreign Exchange Rate Adjustment | -$361.5K | -$112.2K | $214.8K | $1.6M | -$526.1K | |
Additions / Reductions | -$12.5M | $1M | -$2.9M | -$10.2M | $28.7M | |
Ending Cash (CF) | $482K | $2M | $1.7M | $1.1M | $31.4M | |
Levered Free Cash Flow | -$17.4M | -$14.1M | -$9.1M | -$18.9M | $21.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $27.9M | $23.8M | $6.7M | $11.7M | -$533.6K | |
Depreciation & Amoritzation | $12M | $13.8M | $13.3M | $14.3M | $15.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$8.5M | $4.2M | -$3.1M | -$4M | $3.6M | |
Change in Inventories | -$50.2M | -$27M | $21.4M | -$14.7M | $26.3M | |
Cash From Operations | -$64.1K | $11.9M | $31.5M | $18.4M | $43.5M | |
Capital Expenditures | $5.7M | $8.8M | $2.2M | $2.8M | $4.3M | |
Cash Acquisitions | -- | -- | -- | -- | -$324.7K | |
Cash From Investing | -$5.8M | -$8.9M | -$2.1M | -$2.8M | -$4.3M | |
Dividends Paid (Ex Special Dividend) | -$10.5M | -$11.4M | -$8.4M | -$6.5M | -$7.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $9.1M | $58.1M | $16.4M | $27.5M | $52.4M | |
Long-Term Debt Repaid | -$13.8M | -$37.5M | -$28.4M | -$27.9M | -$38.8M | |
Repurchase of Common Stock | -- | -- | -- | -$217.2K | -$648.6K | |
Other Financing Activities | -- | $244.9K | $219.6K | -- | -$850.9K | |
Cash From Financing | -$25.1M | -$1.3M | -$30.3M | -$17.5M | -$7.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31M | $1.7M | -$956.9K | -$1.9M | $31.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$5.8M | $3.1M | $29.3M | $15.6M | $39.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.1M | $4.7M | -- | $1.3M | -$4.2M | |
Depreciation & Amoritzation | $3.6M | $3.4M | $3.4M | $3.8M | $4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$4.9M | $1.2M | -$2.7M | -$2.6M | $105.2K | |
Change in Inventories | -$35.2M | -$15.4M | -$10.2M | -$21.8M | $20.5M | |
Cash From Operations | -$15.9M | -$12.7M | -$8.7M | -$17.6M | $23.1M | |
Capital Expenditures | $1.4M | $1.5M | $429.6K | $1.3M | $1.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.4M | -$1.6M | -$429.6K | -$1.3M | -$1.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $8.7M | $24.8M | $15.5M | $14.9M | $10.5M | |
Long-Term Debt Repaid | -$1.2M | -$6.7M | -$6.7M | -$4M | -$210.5K | |
Repurchase of Common Stock | -- | -- | -- | -$217.2K | -- | |
Other Financing Activities | -$120.5K | -$112.2K | $107.4K | $869K | -$631.3K | |
Cash From Financing | $4.8M | $15.3M | $6.2M | $8.7M | $6.7M | |
Beginning Cash (CF) | $13.5M | $1M | $4.5M | $9.7M | $3.2M | |
Foreign Exchange Rate Adjustment | -$361.5K | -$112.2K | $214.8K | $1.6M | -$526.1K | |
Additions / Reductions | -$12.5M | $1M | -$2.9M | -$10.2M | $28.7M | |
Ending Cash (CF) | $482K | $2M | $1.7M | $1.1M | $31.4M | |
Levered Free Cash Flow | -$17.4M | -$14.1M | -$9.1M | -$18.9M | $21.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.